Skip to content

NTHI NTHI Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Merck & Co. logo
Merck & Co.MRK
$157M+726%
Nuvectis Pharma, Inc. logo
Nuvectis Pharma, Inc.NVCT
$3.95M+339%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$60.88M
Nuvation Bio logo
Nuvation BioNUVB
$908K-16.1%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$380.51M

Other financials

Income statement

See full
Revenue$40.0K-7.0%
Operating income-$7.1M+77.9%
Net income-$8.8M+72.7%
EPS (diluted)-$0.38+78.7%

Balance sheet

See full
Cash & equivalents$138.6K-97.5%
Total debt$666.1K
Total equity-$13.2M-37.5%
Total assets$3.3M-60.6%

Cash flow

See full
Operating cash flow-$7.0M-23.7%
CapEx$125.0K
Free cash flow-$5.2M

Valuation

See full
Market cap$114.62M+51.0%
Enterprise value$115.15M+51.1%
P/S1,432.9×

Profitability

See full
Operating margin-46,870.7%
Net margin-51,613.3%
FCF margin-26,083.2%

Returns & leverage

See full
Return on equity338.1%
Debt / equity-0.1×
Current ratio0.1×-0.3×

Where this comes from

Reported directly by NTHI in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOrSaleOfEquity.

The official record: NTHI’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about NTHI's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NTHI's stock issuance proceeds?
NTHI (NTHI) reported stock issuance proceeds of $2 in Q4 2025.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.